vials_purple_liquid

Alphabet’s life science unit makes device to aid gathering of health data for research

pharmafile | March 11, 2016 | News story | Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences 

Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for people participating in clinical studies in a filing with the US Securities and Exchange Commission this week.

The wireless hub can be installed in medical facilities and allows data collected with various sensors to be uploaded to the cloud for analysis.

Freshly release photos of the Connectivity Bridge show the device is easily adaptable for use in a home or medical facility. The US Federal Communications Commission approved the Connectivity Bridge last year.

Verily is working in the area of nanodiagnostics, a sort of baseline project that utilizes big data to assimilate all of a person’s genetic and healthcare data. The company is focussing on developing combination products that utilise big data and healthcare. The company is also engaged in researching and developing other biological data monitors.

Drug companies are increasingly looking at tapping into wearable technologies that can collect health-related data to develop new treatments.

Alphabet is the parent company of Google.

Anjali Shukla

Related Content

scotland

Scotland’s life sciences sector on track to break $8 billion by 2025

A new report from the Scottish Government has revealed that the country’s life sciences sector …

Google accused of profiting from misleading dementia supplement ads

Google has been accused of profiting from false hope after running adverts for unproven dementia …

boardroom

The value of measuring biotech Board performance

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness …

Latest content